MURA Live signaler | Maksimer profitt med Getagraph.com

KJøP 120597 min ago

@ $4.55

Utstedt: 14 feb 2024 @ 18:08

Avkastning: -15.82%

Forrige signal: feb 14 - 15:34

Forrige signal: Selg

Avkastning: -0.44 %

Live Chart Being Loaded With Signals

Commentary (7 mai 2024 @ 22:00):

Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer...

Stats
Dagens volum	90 466.00
Gjennomsnittsvolum	234 291
Markedsverdi	64.81M
EPS	$0 ( 2024-03-14 )
Neste inntjeningsdato	( $-2.66 ) 2024-06-25
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.00500 (0.13%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-14	Cuss Francis M	Buy	15 021	Stock Option (right to buy)
2023-12-14	Jackson Scott Thomas	Buy	15 021	Stock Option (right to buy)
2023-12-14	Hickey Benjamin	Buy	15 021	Stock Option (right to buy)
2023-12-14	Cutler Adam D.	Buy	146 452	Stock Option (right to buy)
2023-12-14	Cutler Adam D.	Buy	78 859	Ordinary Shares

INSIDER POWER
100.00
Last 10 transactions
Buy: 353 823 \| Sell: 0

Volum Korrelasjon

Lang: 0.09 (neutral)

Kort: -0.86 (strong negative)

Signal:(49.865) Neutral

Mural Oncology plc Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Mural Oncology plc Korrelasjon - Valuta/Råvare

0.25
( neutral )

0.00
( neutral )

-0.37
( neutral )

0.81
( strong )

Mural Oncology plc Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-2.57M (0.00 %)
EPS:	$-12.43

FY	2023
Omsetning:	$0
Bruttogevinst:	$-2.57M (0.00 %)
EPS:	$-12.43

FY	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-11.99

Financial Reports:

No articles found.

Mural Oncology plc

Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. The company was incorporated in 2017 and is based in Dublin, Ireland. As of November 15, 2023, Mural Oncology Plc operates as a former subsidiary of Alkermes plc.